Crumly & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Medical Devices ETF
IHI
|
+$4.46M |
| 2 |
First Trust Global Tactical Commodity Strategy Fund
FTGC
|
+$3.09M |
| 3 |
First Trust Materials AlphaDEX Fund
FXZ
|
+$2.48M |
| 4 |
First Trust Financials AlphaDEX Fund
FXO
|
+$1.89M |
| 5 |
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
|
+$1.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Capital Strength ETF
FTCS
|
+$1.91M |
| 2 |
First Trust Senior Loan Fund ETF
FTSL
|
+$1.62M |
| 3 |
Distillate US Fundamental Stability & Value ETF
DSTL
|
+$1.59M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.08M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.71% |
| 2 | Consumer Discretionary | 2.18% |
| 3 | Financials | 1.87% |
| 4 | Healthcare | 1.64% |
| 5 | Materials | 1.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Citizens Financial Group
CFG
$30.5B
| $207K | 0.09% |
6,029
| – | – |
|
102
iShares Gold Trust
IAU
$66B
| $207K | 0.09% |
6,560
-215
| -3% | -$7.05K |
|
103
Fidelity MSCI Industrials Index ETF
FIDU
$2.38B
| $201K | 0.08% |
4,608
| – | – |
|
104
Purple Innovation
PRPL
$39.3M
| $94K | 0.04% |
931
+400
| +75% | +$34.7K |
|
|
105
First Trust Capital Strength ETF
FTCS
$7.93B
| – | – |
-27,266
| Closed | -$1.91M |
|
|
106
First Trust Senior Loan Fund ETF
FTSL
$2.33B
| – | – |
-36,634
| Closed | -$1.62M |
|
107
GT Biopharma
GTBP
$10.9M
| – | – |
-1,072
| Closed | -$96K |
|
108
iShares Global 100 ETF
IOO
$9.19B
| – | – |
-3,141
| Closed | -$201K |
|
Similar funds
Crumly & Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Crumly & Associates held 108 positions worth $242M, up 0.72% from $241M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Crumly & Associates deployed $15.5M of net new capital in Q3 2022, opening 2 new positions and adding to 60 existing holdings. Its largest new stake was W.P. Carey: 3,144 shares worth $215K.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 2.8% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Distillate US Fundamental Stability & Value ETF, an estimated $1.59M trimmed.
- Crumly & Associates's largest Q3 2022 buy was W.P. Carey: 3,144 shares worth $215K.
- Crumly & Associates added most to iShares US Medical Devices ETF in Q3 2022, an estimated $4.46M increase.
- Crumly & Associates's biggest Q3 2022 reduction was Distillate US Fundamental Stability & Value ETF, cutting an estimated $1.59M.
- Crumly & Associates fully exited First Trust Capital Strength ETF in Q3 2022, selling an estimated $1.91M.
- Crumly & Associates's ten largest holdings make up 48% of its $242M portfolio in Q3 2022.
- Crumly & Associates opened 2 new positions and closed 4 in Q3 2022.
- Crumly & Associates's portfolio value rose 0.72% quarter-over-quarter to $242M.
Based on Crumly & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.